05.31.22
Stratum Nutrition, in conjunction with Blis Technologies, announced the release of dairy-free versions of two probiotic strains branded as BLIS K12 and BLIS M18. Stratum is the North American distributor for Blis Technologies. The release of both allergen-free ingredients is helpful to those seeking to formulate dairy-free probiotic lines.
“We are pleased to offer Stratum customers dairy-free versions of BLIS K12 and BLIS M18, recognizing that a proportion of consumers may have had allergens to dairy that have prevented them from accessing our probiotic strains,” said Brian Watson, CEO of Blis Technologies. “We have partnered with Sacco System, a probiotic fermentation expert, to develop these versions of the strains and provide ongoing supply. It is important to note that we will continue to offer the original versions of both BLIS K12 and BLIS M18 that have been trusted by a wide range of customers over many years.”
Blis Technologies specializes in oral probiotic supplements, and Streptococcus salivarius is the dominant organism present and several strains have been shown to produce favorable bacteriocin-like inhibitory substances (BLIS). BLIS K12 and BLIS M18 are both strains of S. salivarius.
BLIS K12 helps maintain ear, nose, and throat health and is formulated for immune support. Its safety and efficacy in children and adults is backed by a portfolio of research spanning 30 years. BLIS M18 is formulated to be used in conjunction with oral hygiene practices to establish a healthy balance of bacteria in the mouth to support healthy teeth and gums, as well as overall health.
“We are proud to be partnered with Blis Technologies as they continue to pursue research to provide high quality probiotic solutions,” said Micah Osbourne, CEO of Stratum Nutrition. “The BLIS ingredients have been a key part of our proprietary branded ingredient portfolio. We are excited to be able to build on this with the addition of dairy-free BLIS K12 and BLIS M18.”
“We are pleased to offer Stratum customers dairy-free versions of BLIS K12 and BLIS M18, recognizing that a proportion of consumers may have had allergens to dairy that have prevented them from accessing our probiotic strains,” said Brian Watson, CEO of Blis Technologies. “We have partnered with Sacco System, a probiotic fermentation expert, to develop these versions of the strains and provide ongoing supply. It is important to note that we will continue to offer the original versions of both BLIS K12 and BLIS M18 that have been trusted by a wide range of customers over many years.”
Blis Technologies specializes in oral probiotic supplements, and Streptococcus salivarius is the dominant organism present and several strains have been shown to produce favorable bacteriocin-like inhibitory substances (BLIS). BLIS K12 and BLIS M18 are both strains of S. salivarius.
BLIS K12 helps maintain ear, nose, and throat health and is formulated for immune support. Its safety and efficacy in children and adults is backed by a portfolio of research spanning 30 years. BLIS M18 is formulated to be used in conjunction with oral hygiene practices to establish a healthy balance of bacteria in the mouth to support healthy teeth and gums, as well as overall health.
“We are proud to be partnered with Blis Technologies as they continue to pursue research to provide high quality probiotic solutions,” said Micah Osbourne, CEO of Stratum Nutrition. “The BLIS ingredients have been a key part of our proprietary branded ingredient portfolio. We are excited to be able to build on this with the addition of dairy-free BLIS K12 and BLIS M18.”
